GleamWall
中文EN

NGVT Ingevity Corp

Chemicals & Allied Products · NYSE · SEC CIK 1653477 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-3.7%
TTM net income YoY190.7%
TTM EPS YoY196.1%
Revenue 3-yr CAGR-12.7%
Net income 3-yr CAGR-22.2%

Margins

Gross margin42.0%
Operating margin—
Net margin5.3%
FCF margin10.8%
EBITDA margin—

Returns

ROE59.5%
ROA3.6%
ROIC (approx.)—
Asset turnover0.68x

Leverage & solvency

Liabilities / assets95.8%
Debt / equity18.18x
Current ratio1.48x
Interest coverage—

Cash quality & payout

Operating cash flow / net income3.02x
Accruals ratio-7.2%
Payout ratio—
Capex / revenue5.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$1.17B$1.20B$1.22B$1.67B$1.39B
Cost of revenue$706.10M$735.30M$770.50M$1.10B$878.70M
Gross profit$461.50M$464.80M$445.00M$570.10M$512.80M
R&D expense$28.40M$24.50M$25.40M$30.30M$26.30M
SG&A expense$171.20M$157.80M$161.80M$198.80M$179.30M
Operating income$418.70M$425.90M$423.20M$452.60M$422.20M
Interest expense$78.30M$97.80M$93.30M$61.80M$51.70M
Pretax income-$142.10M-$140.50M$130.00M$269.60M$162.80M
Income tax$8.20M-$19.10M$24.20M$58.00M$44.70M
Net income-$167.10M-$430.30M-$5.40M$211.60M$118.10M
EBITDA$525.10M$534.20M$546.00M$561.40M$532.10M
EPS (basic)-4.61-11.85-0.155.542.97
EPS (diluted)-4.61-11.85-0.155.502.95
Weighted avg. shares (diluted)36.22M36.32M36.71M38.47M40.06M
Balance sheet
Cash & equivalents$78.10M$68.00M$95.90M$84.30M$280.70M
Inventory$186.00M$195.90M$308.80M$335.00M$241.20M
Current assets$454.20M$493.20M$658.60M$683.30M$724.90M
PP&E, net$608.10M$642.90M$762.20M$798.60M$719.70M
Goodwill$4.30M$175.20M$527.50M$518.50M$442.00M
Intangibles$176.10M$278.80M$336.10M$404.80M$337.60M
Total assets$1.65B$2.02B$2.62B$2.74B$2.47B
Current liabilities$341.30M$264.10M$362.90M$303.50M$268.90M
Short-term debt$47.10M$61.30M$84.40M$900,000$19.60M
Long-term debt$1.16B$1.34B$1.38B$1.47B$1.25B
Total debt$1.21B$1.40B$1.47B$1.47B$1.27B
Total liabilities$1.62B$1.83B$1.99B$2.04B$1.80B
Shareholders' equity$29.70M$195.20M$631.40M$698.30M$673.80M
Net debt$1.13B$1.33B$1.37B$1.39B$988.90M
Shares outstanding35.49M36.35M36.23M37.30M39.27M
Cash flow statement
Operating cash flow$331.20M$128.60M$205.10M$313.40M$293.30M
Capital expenditure$57.70M$77.60M$109.80M$142.50M$103.80M
Free cash flow$273.50M$51.00M$95.30M$170.90M$189.50M
Investing cash flow-$57.50M-$79.50M-$77.30M-$551.90M-$138.60M
Financing cash flow-$252.20M-$70.20M-$99.90M$48.10M-$133.10M
Depreciation & amortization$106.40M$108.30M$122.80M$108.80M$109.90M
Stock-based compensation$18.30M$11.90M$10.60M$16.10M$12.30M
Share buybacks$56.30M$0$92.10M$145.20M$109.40M

Free plan shows the latest 5 periods; Pro shows all 12 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.